 CAMBRIDGE, Mass., Aug. 02, 2022 GLOBE NEWSWIRE -- Vigil Neuroscience, Inc. Nasdaq: VIGL, a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced that members of the management team will participate in a fireside chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference on Tuesday, August 9, 2022 at 11:30 a.m. ET. 